Compare T-Rex 2X Long MSTR Daily Target ETF (MSTU) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
T-Rex 2X Long MSTR Daily Target ETF vs Novavax Inc — how do they compare? T-Rex 2X Long MSTR Daily Target ETF trades at $2.14, while Novavax Inc trades at $8.06 (market cap $1.30B). The key difference: Novavax Inc is trading nearer its 52-week high, T-Rex 2X Long MSTR Daily Target ETF nearer its low. Which is the better fit depends on your goals.
| MSTU | NVAX | |
|---|---|---|
Sector | Leveraged / Inverse | Health |
52-Week High | $92.70 | $11.19 |
52-Week Low | $1.46 | $6.22 |
Market Cap | — | $1.30B |
Enterprise Value | — | $800.50M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About T-Rex 2X Long MSTR Daily Target ETF
MSTU is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bullish (long) position in MSTR, a company known for its significant Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on MSTU →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
